» Articles » PMID: 1848205

Early Stages of Multistep Hepatocarcinogenesis: Adenomatous Hyperplasia and Early Hepatocellular Carcinoma

Overview
Journal Hum Pathol
Specialty Pathology
Date 1991 Feb 1
PMID 1848205
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

From a series of 320 heptocellular carcinoma (HCC) cases treated surgically, we selected small nodular lesions that had not destroyed the preexisting liver structure grossly. After excluding metastases and large regenerative nodules, 58 lesions from 41 cases were chosen. All the lesions were hypercellular. Among them, 33 lesions showing histologic features of very well-differentiated HCC (Edmondson grade I), that is, small hepatocytes with little cellular atypia but with structural atypia, such as a thin trabecular structure of acinar formation in some areas, were classified as early HCC (eHCC). In seven eHCCs, areas of overt carcinoma, classified as Edmondson grade II, were found in the background of Edmondson grade I carcinoma. The remaining 25 lesions lacked structural atypia and were classified as adenomatous hyperplasia (AH). Among the AHs, 10 nodules with a very focal abnormal structure were subclassified as atypical adenomatous hyperplasia (AAH). There was a tendency for the size and cellularity of the atypical lesions to increase in order from AH to AAH to eHCC. All nodules larger than 1.5 cm were eHCC. A degree of cellularity more than twice that of a regenerative nodular was suggested to be an indicator of HCC. All small nodular lesions were associated with chronic liver disease. These histologic observations appear to explain the stepwise development of overt HCC from very well-differentiated eHCC, and of eHCC from AH probably through AAH, at least in cases of HCC associated with chronic liver disease.

Citing Articles

Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.

Yahia Y, Qasem M, Abbarh S, Saffo H, Obeidat I, Barjas H J Gastrointest Cancer. 2024; 56(1):1.

PMID: 39414724 PMC: 11485135. DOI: 10.1007/s12029-024-01122-7.


MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma.

Xiao Y, Wu F, Hou K, Wang F, Zhou C, Huang P Insights Imaging. 2024; 15(1):172.

PMID: 38981992 PMC: 11233482. DOI: 10.1186/s13244-024-01741-5.


IDEAL-IQ measurement can distinguish dysplastic nodule from early hepatocellular carcinoma: a case-control study.

Zheng G, Wei F, Lu P, Yang G, Li C, Lin C Quant Imaging Med Surg. 2024; 14(6):3901-3913.

PMID: 38846285 PMC: 11151266. DOI: 10.21037/qims-23-1593.


Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms.

Sayed G, Solyman M, El Gedawy G, Moemen Y, Aboul-Ella H, Hassanien A Sci Rep. 2024; 14(1):4989.

PMID: 38424116 PMC: 10904762. DOI: 10.1038/s41598-024-54795-2.


Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement.

Brandi N, Renzulli M J Clin Transl Hepatol. 2024; 12(1):100-112.

PMID: 38250460 PMC: 10794268. DOI: 10.14218/JCTH.2023.00130.